Cargando…
Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease
Background: Hepatocellular carcinoma (HCC) occurs in the majority of patients with underlying chronic liver disease (CLD) of viral and non-viral etiologies, which requires screening for early HCC diagnosis. Liquid biopsy holds great promise now for early detection, prognosis, and assessment of respo...
Autores principales: | Kumar, Sonu, Nadda, Neeti, Paul, Shashi, Gamanagatti, Shivanand, Dash, Nihar Ranjan, Vanamail, Perumal, Saraya, Anoop, Shalimar, Nayak, Baibaswata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723134/ https://www.ncbi.nlm.nih.gov/pubmed/36483538 http://dx.doi.org/10.3389/fmolb.2022.1024193 |
Ejemplares similares
-
Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma
por: Kumar, Sonu, et al.
Publicado: (2023) -
Prognostic and Therapeutic Potentials of OncomiRs Modulating mTOR Pathways in Virus-Associated Hepatocellular Carcinoma
por: Nadda, Neeti, et al.
Publicado: (2021) -
Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility
por: Roy, Neelanjana, et al.
Publicado: (2022) -
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases
por: Nayak, Baibaswata, et al.
Publicado: (2021) -
Extracellular Vesicle-Associated miRNAs as a Biomarker for Lung Cancer in Liquid Biopsy
por: He, Xue, et al.
Publicado: (2021)